Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin

Blood

Volumn 95, Issue 4, 2000, Pages 1451-1455

  Tidow, Nicola ^a,b   Chen, Xiaoguang ^a   Müller, Carsten ^a   Kawano, Seiji ^a   Gombart, Adrian F ^a   Fischel Ghodsian, Nathan ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MESSENGER RNA;

ARTICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0034651904     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1451.004k52_1451_1455     Document Type: Article

References (17)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43:227.
2. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879.
3. The International FMF Consortium: Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797.
4. The French FMF Consortium: A candidate gene for familial Mediterranean fever. Nat Genet. 1997; 17:25.
5. Chen X, Fischel-Ghodsian N, Cercek A, et al. Assessment of pyrin gene mutations in Turks with familial Mediterranean fever (FMF). Hum Mutat. 1998;11:456.
6. Matzner Y, Brzezinski A. C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med. 1984;311: 287.
7. Ayesh SK, Azar Y, Barghouti II, Ruedi JM, Babior BM, Matzner Y. Purification and characterization of a C5a-inactivating enzyme from human peritoneal fluid. Blood. 1995;85:3503.
8. Matzner Y, Eisenberg S, Shperling O, UrieliShoval S. Co-expression of the gene, MEVF, and activity of the C5a/IL-8 inhibitor in human primary fibroblast cultures [abstract] Blood. 1998; 92(suppl 1):698a.
9. Boyum A. Separation of white blood cells. Nature. 1964;204:793.
10. Ferrante A, Thong YH. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leukocytes from human peripheral blood by Ficoll-Hypaque method. J Immunol Methods. 1980;36:109.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem. 1987;162:156.
12. Centola M, Aksentijevich I, Kastner DL. The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet. 1998;7:1581.
13. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415.
14. Tenjinbaru K, Furuno T, Hirashima N, Nakanashi M. Nuclear translocation of green fluorescent protein-nuclear factor kappaB with a distinct lag time in living cells. FEBS Lett. 1999;444:1.
15. Kremmidiotis G, Lensink IL, Bilton RL, et al. The Batten disease gene product (CLN3p) is a Golgi integral membrane protein. Hum Mol Genet. 1999;8:523.
16. Tissot C, Mechti N. Molecular cloning of a new interferon-induced factor that depresses immuno-deficiency virus type 1 long terminal repeat expression. J Biol Chem. 1995;270:14,891.
17. Takahashi M, Inaguma Y, Hiai H, Hirose F. Developmentally regulated expression of a human "finger"-containing gene encoded by the 5′ half of the ret transforming gene. Mol Cell Biol. 1988;8: 1853, 1988.